That's a great question to bring up with a nephrologist! The available search results don't contain specific information about sparsentan and FSGS (focal segmental glomerulosclerosis), so a confident answer can't be provided here.
What is known is that sparsentan (Filspari) received FDA approval for IgA nephropathy (IgAN) Show Full Answer
That's a great question to bring up with a nephrologist! The available search results don't contain specific information about sparsentan and FSGS (focal segmental glomerulosclerosis), so a confident answer can't be provided here.
What is known is that sparsentan (Filspari) received FDA approval for IgA nephropathy (IgAN), not specifically for FSGS.
For the most accurate and personalized guidance, it's really important to:
- Speak directly with your kidney specialist
- Ask about the latest treatment options approved or being studied for FSGS
- Discuss your specific kidney function, proteinuria levels, and overall health when considering any treatment
July 21
Join
Your Privacy Choices
